The Wiskott-Aldrich Foundation

The Wiskott-Aldrich Foundation Seeking cures and better treatment for Wiskott-Aldrich Syndrome

The Wiskott-Aldrich Foundation is a non-profit organization dedicated to funding research to find better cures and treatment for Wiskott-Aldrich Syndrome (WAS), education for families and doctors, and to provide support for families living with WAS worldwide.

https://www.youtube.com/watch?v=aN4ldCwBnFIIn this episode of Immune Matters (a podcast by Primary Immune Deficiency Tre...
05/27/2026

https://www.youtube.com/watch?v=aN4ldCwBnFI

In this episode of Immune Matters (a podcast by Primary Immune Deficiency Treatment Consortium - PIDTC), hosts Jack McDonnell and Elie Haddad speak with Dr. Simon Tabchi, a physician, transplant survivor, and advocate living with a history of Wiskott-Aldrich Syndrome (WAS). Simon shares his childhood diagnosis, bone marrow transplant journey, and how surviving a rare primary immunodeficiency inspired his career in medicine and patient advocacy.

The discussion explores the patient perspective of transplantation, including prolonged isolation, recovery, family impact, and the importance of early treatment. Simon also reflects on how newer options such as gene therapy are expanding hope for families facing WAS today.

The episode concludes with a conversation about survivorship, mentorship, and the value of connecting newly diagnosed families with those who have already walked the path. Simon explains how advocacy can help patients navigate both treatment and life after transplant.

https://www.youtube.com/watch?v=aN4ldCwBnFI

, , , ,

REMINDER TO REGISTER!https://forms.gle/jAEB4FjieyPsfDNHAManagement of Wiskott-Aldrich Syndrome is Changing: Understandin...
05/15/2026

REMINDER TO REGISTER!
https://forms.gle/jAEB4FjieyPsfDNHA

Management of Wiskott-Aldrich Syndrome is Changing: Understanding Today's Global Guidelines

Date: Saturday, May 23, 2026
Time: 11:00 AM – 12:00 PM EDT

Webinar focus:

In this session, Dr. Albert will provide an overview of how the approach to WAS is evolving, including:

A new classification system for WAS that better reflects disease variability
Updated HSCT guidelines for all patients, including both mild and severe forms of the disease
Management of the untransplanted patient with WAS
New recommendations on which patients should be considered for gene therapy
For the first time, the inclusion of mental health and psychosocial care guidelines as part of comprehensive WAS management
This webinar will help families understand what these changes mean in practice and how they may influence care decisions moving forward.

To register, please go to: https://forms.gle/jAEB4FjieyPsfDNHA
You will receive the Zoom link a few days before the session.

Speaker:
Michael Albert, M.D.: Dr. Albert brings decades of experience in hematopoietic stem cell transplantation and caring for patients with primary immunodeficiencies. He previously served as Head of the Stem Cell Transplant Program in the Department of Pediatric Hematology/Oncology at Dr. von Haunersches Children’s Hospital, where he led clinical and research efforts in Wiskott-Aldrich Syndrome (WAS) and related disorders.

His work has contributed to several influential publications that have shaped the current understanding and treatment approaches for WAS. More recently, Dr. Albert transitioned to DKMS, as Pediatric Stem Cell Transplantation Expert where he is applying his extensive clinical and scientific expertise to support and expand transplant programs globally, with the goal of improving access to curative therapies for patients worldwide.

Moderator:
Prof. Fabio Candotti, Professor of Medicine at the University of Lausanne and Head Physician in Immunology and Allergy at Lausanne University Hospital, Switzerland. An internationally recognized expert in primary immunodeficiencies, his work has focused on Wiskott-Aldrich Syndrome, ADA deficiency, and gene therapy. Dr. Candotti is the Chairman of the Scientific Advisory Board of the Wiskott-Aldrich Foundation and has advised the foundation in all scientific matters for the past 17 years.

We encourage patients, caregivers, and family members to join us for this informative session and the opportunity to ask questions.

Who can attend:

This webinar is designed for and open only to patients, parents, and family members with Wiskott-Aldrich Syndrome and their families (participants should be over 18 years of age).

We hope you will be able to join us for this meaningful conversation.

How Does Registration Work?

Registered participants will receive an email several days before the meeting containing information about joining the meeting. The email will include a link on how to join the meeting and will include phone numbers where you can join by telephone.

Please RSVP by May 22, 2026. If you have specific questions for the doctors, please enter them below. There is no cost to attend.
Register here: https://forms.gle/jAEB4FjieyPsfDNHA

As part of our 2026 monthly webinar series, the Wiskott-Aldrich Foundation continues to bring leading experts to speak d...
05/07/2026

As part of our 2026 monthly webinar series, the Wiskott-Aldrich Foundation continues to bring leading experts to speak directly with our global community of patients and families. For the May session, we are pleased to host Dr. Michael Albert who has kindly agreed to conduct the webinar on:

Management of Wiskott-Aldrich Syndrome is Changing: Understanding Today's Global Guidelines

This session is especially timely, as there are new global consensus guidelines for Wiskott-Aldrich Syndrome (WAS). These recommendations reflect a significant shift in how WAS is understood and managed—and we are committed to sharing this information early with our community.

Date: Saturday, May 23, 2026
Time: 11:00 AM – 12:00 PM EDT

Webinar focus:
The management of Wiskott-Aldrich Syndrome is undergoing important changes based on global consensus recommendations. Historically, treatment decisions were often guided by a narrower classification of disease severity, with clearer pathways primarily for the most severe cases. Today, a more nuanced understanding of WAS is shaping a broader, more individualized approach to care across the full disease spectrum.

In this session, Dr. Albert will provide an overview of how the approach to WAS is evolving, including:

* A new classification system for WAS that better reflects disease variability
* Updated HSCT guidelines for all patients, including both mild and severe forms of the disease
* Management of the untransplanted patient with WAS
New recommendations on which patients should be considered for gene therapy
* For the first time, the inclusion of mental health and psychosocial care guidelines as part of comprehensive WAS management
This webinar will help families understand what these changes mean in practice and how they may influence care decisions moving forward.

To register, please go to: https://forms.gle/UeycW6EvNbBxsq2ZA
You will receive the Zoom link a few days before the session.

Speaker:
Michael Albert, M.D.: Dr. Albert brings decades of experience in hematopoietic stem cell transplantation and caring for patients with primary immunodeficiencies. He previously served as Head of the Stem Cell Transplant Program in the Department of Pediatric Hematology/Oncology at Dr. von Haunersches Children’s Hospital, where he led clinical and research efforts in Wiskott-Aldrich Syndrome (WAS) and related disorders.

His work has contributed to several influential publications that have shaped the current understanding and treatment approaches for WAS. More recently, Dr. Albert transitioned to DKMS, as Pediatric Stem Cell Transplantation Expert where he is applying his extensive clinical and scientific expertise to support and expand transplant programs globally, with the goal of improving access to curative therapies for patients worldwide.

Moderator:
Prof. Fabio Candotti, Professor of Medicine at the University of Lausanne and Head Physician in Immunology and Allergy at Lausanne University Hospital, Switzerland. An internationally recognized expert in primary immunodeficiencies, his work has focused on Wiskott-Aldrich Syndrome, ADA deficiency, and gene therapy. Dr. Candotti is the Chairman of the Scientific Advisory Board of the Wiskott-Aldrich Foundation and has advised the foundation in all scientific matters for the past 17 years.

We encourage patients, caregivers, and family members to join us for this informative session and the opportunity to ask questions.

Who can attend:

This webinar is designed for and open only to patients, parents, and family members with Wiskott-Aldrich Syndrome and their families (participants should be over 18 years of age).

We hope you will be able to join us for this meaningful conversation.

How Does Registration Work?

Registered participants will receive an email several days before the meeting containing information about joining the meeting. The email will include a link on how to join the meeting and will include phone numbers where you can join by telephone.

Please RSVP by May 20 , 2026. If you have specific questions for the doctors, please enter them on the registration form.
There is no cost to attend.
REGISTER HERE: https://forms.gle/UeycW6EvNbBxsq2ZA

1 MORE HOUR BEFORE THE WEBINAR BEGINS.  FAMILIES, REGISTER NOW AND WE WILL EMAIL THE ZOOM LINK TO YOU. We are pleased to...
03/28/2026

1 MORE HOUR BEFORE THE WEBINAR BEGINS. FAMILIES, REGISTER NOW AND WE WILL EMAIL THE ZOOM LINK TO YOU.

We are pleased to share that Dr. Lauri Burroughs has kindly agreed to present an educational session on hematopoietic stem cell transplantation (HSCT) for individuals affected by Wiskott-Aldrich Syndrome and their families.

Topic: Hematopoietic Stem Cell Transplantation for Wiskott–Aldrich Syndrome: Current Practice, Recent Advances, and Long-Term Outcomes

Join us for a focused presentation by Dr. Burroughs, moderated by Dr. Fabio Candotti, providing an overview of HSCT as a curative treatment option for Wiskott-Aldrich Syndrome (WAS).

This session will comprehensively discuss when HSCT is considered, how transplant decisions are made, and what patients and families can expect before, during, and after transplant. Drawing on extensive multicenter experience, including work through the Primary Immune Deficiency Treatment Consortium (PIDTC), Dr. Burroughs will review current practices and long-term outcomes for patients with WAS undergoing transplantation.

When: Saturday, March 28th. 11:00 AM- 12:00 PM (EDT)
Speaker: Lauri Burroughs, M.D.
Moderator: Fabio Candotti, M.D.
Who can attend:
Patients with Wiskott-Aldrich syndrome and their families (participants should be over 18 years of age)
Where:
Virtual Zoom

⭐REGISTRATION⭐
Please go to https://forms.gle/M7Nwq5nowHg1rS9R6
There is no cost to attend. You will receive a Zoom link before the meeting.

03/17/2026

The Scholarship Fund is approaching its 500th recipient since launching in 2020. Could it be you?

Applications are now open for the RAREis Scholarship Fund. Thanks to the support of Amgen's RAREis program, the EveryLife Foundation for Rare Diseases will award 58 scholarships of $5,000 to individuals in the rare disease community pursuing higher education in Fall 2026.

Learn more and apply at https://hubs.li/Q04756qS0. Application closes April 28 at 2 PM Eastern.

We are pleased to share that Dr. Lauri Burroughs has kindly agreed to present an educational session on hematopoietic st...
03/06/2026

We are pleased to share that Dr. Lauri Burroughs has kindly agreed to present an educational session on hematopoietic stem cell transplantation (HSCT) for individuals affected by Wiskott-Aldrich Syndrome and their families.

Topic: Hematopoietic Stem Cell Transplantation for Wiskott–Aldrich Syndrome: Current Practice, Recent Advances, and Long-Term Outcomes

Join us for a focused presentation by Dr. Burroughs, moderated by Dr. Fabio Candotti, providing an overview of HSCT as a curative treatment option for Wiskott-Aldrich Syndrome (WAS).

This session will comprehensively discuss when HSCT is considered, how transplant decisions are made, and what patients and families can expect before, during, and after transplant. Drawing on extensive multicenter experience, including work through the Primary Immune Deficiency Treatment Consortium (PIDTC), Dr. Burroughs will review current practices and long-term outcomes for patients with WAS undergoing transplantation.

When: Saturday, March 28th. 11:00 AM- 12:00 PM (EDT)

Speaker: Lauri Burroughs, M.D.
Moderator: Fabio Candotti, M.D.

Who can attend:
Patients with Wiskott-Aldrich syndrome and their families (participants should be over 18 years of age)

Where:
Virtual Zoom

⭐REGISTRATION⭐
Please go to https://forms.gle/M7Nwq5nowHg1rS9R6
There is no cost to attend. You will receive a Zoom link a few days before the meeting.

Great opportunity to learn more about gene therapy!Join the upcoming JMF Speaker Series featuring Dr. Donald B. Kohn pre...
03/06/2026

Great opportunity to learn more about gene therapy!

Join the upcoming JMF Speaker Series featuring Dr. Donald B. Kohn presenting: “Gene Therapy for Inborn Errors of Immunity: It’s taken us so long ’cause we’ve got so far to come.”

Moderated by Dr. Jordan Orange, this important conversation will explore the progress, promise, and future of gene therapy for Inborn Errors of Immunity.

📣Have you registered yet? We are partnering with The Columbia University to offer CME credits!

Join us for our upcoming JMF Speaker Series featuring Dr. Donald B. Kohn presenting: “Gene Therapy for Inborn Errors of Immunity: It’s taken us so long ’cause we’ve got so far to come.”

Moderated by Dr. Jordan Orange, this important conversation will explore the progress, promise, and future of gene therapy for Inborn Errors of Immunity.

✅ Registration is FREE! Secure your spot here: bit.ly/3Oa2RYW

Thank you for taking the time to join us for our Educational Webinar on Saturday, February 28, titled “Clinical Spectrum...
03/04/2026

Thank you for taking the time to join us for our Educational Webinar on Saturday, February 28, titled “Clinical Spectrum of WAS Carriers.” We were grateful to see so many families participate and engage in this important conversation.

A special thank you to Dr. Suhag Parikh for presenting and sharing insights from the latest research, and to Dr. Fabio Candotti for moderating the discussion and helping guide the conversation.

The thoughtful questions and participation made the webinar especially meaningful. We hope the discussion helped to gain a better understanding of the clinical spectrum of WAS carriers and provided useful information.

If you would like to view recorded webinar, it's on the WAF YouTube channel:
https://www.youtube.com/watch?v=_V8fu8bAEgA

We are deeply grateful for this community and for your continued commitment to learning, sharing, and supporting our efforts.

With appreciation,
The WAF Educational Webinar Team

01/29/2026

FROM GRIEF TO GRATITUDE:
The Extraordinary Journey of José Luis and His Family

In 2013, we met a small boy from Bolivia named José Luis, whose life hung in the balance. Diagnosed with Wiskott-Aldrich Syndrome, a rare and life-threatening immunodeficiency, his survival depended on a bone marrow transplant - a procedure unavailable in his home country and priced far beyond his family’s means. At just two years old, José Luis was constantly ill, living in isolation, and in desperate need of hope. View the video to learn more about this extraordinary Wiskott Warrior and his family. Jose Luis Montaño Ribera Adela Coca Guzman

💙Happy New Year! 💙 On behalf of the Wiskott-Aldrich Foundation, thank you for supporting our mission and projects in 202...
01/01/2026

💙Happy New Year! 💙 On behalf of the Wiskott-Aldrich Foundation, thank you for supporting our mission and projects in 2025 -- much was accomplished. It will be a pleasure to have you walk with us in 2026 since we still have a lot of work ahead of us.

Wishing you a happy and healthy new year!

Address

PO Box 156
Austell, GA
30168

Alerts

Be the first to know and let us send you an email when The Wiskott-Aldrich Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to The Wiskott-Aldrich Foundation:

Share